Table of Content



1. Research Scope & Methodology

1. Study Objectives

2. Scope Of Study

3. Methodology

4. Assumptions & Limitations

2. Executive Summary

1. Market Size & Estimates

2. Market Overview

3. Market Dynamics

1. Market Definition

2. Key Drivers
3.2.1. Growing Prevalence Of Hypertension Across The Globe
3.2.2. Surge In Disposable Income And Healthcare Spending
3.2.3. Rising Aging Population

3. Key Restraints
3.3.1. Patent Expirations
3.3.2. Delay In Product Launches

4. Key Analytics

1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry

2. Regulatory Framework

3. Opportunity Matrix

4. Vendor Landscape

5. Key Investment Insights

5. Market By Drug Class

1. Calcium Channel Blockers

2. Ace Inhibitors

3. Beta-Adrenergic Blockers

4. Diuretics

5. Vasodilators

6. Other Drug Class

6. Market By End-User

1. Hospital Pharmacy

2. Retail Pharmacy

3. E-Commerce Websites & Online Drug Stores

7. Geographical Analysis

1. Europe
7.1.1. The United Kingdom
7.1.2. France
7.1.3. Germany
7.1.4. Italy
7.1.5. Russia
7.1.6. Belgium
7.1.7. Poland
7.1.8. Rest Of Europe

8. Company Profiles

1. Allergan Plc

2. Aspire Bariatrics Inc

3. Astrazeneca Plc

4. Bio-Rad Laboratories Inc

5. Boehringer Ingelheim International Gmbh

6. Daiichi Sankyo Company Limited

7. Hill-Rom Holdings Inc

8. Johnson & Johnson

9. Lupin Limited
8.10. Medtronic Plc
8.11. Merck & Co Inc
8.12. Novartis Ag
8.13. Pfizer Inc
8.14. Sanofi
8.15. Sun Pharmaceutical Industries Ltd (Ranbaxy Laboratories)



List of Figures


List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Europe Antihypertensive Drugs Market, By Drug Class, In 2019
Figure 6: Europe Antihypertensive Drugs Market, By Calcium Channel Blockers, 2019-2028 (In $ Million)
Figure 7: Europe Antihypertensive Drugs Market, By Ace Inhibitors, 2019-2028 (In $ Million)
Figure 8: Europe Antihypertensive Drugs Market, By Beta-Adrenergic Blockers, 2019-2028 (In $ Million)
Figure 9: Europe Antihypertensive Drugs Market, By Diuretics, 2019-2028 (In $ Million)
Figure 10: Europe Antihypertensive Drugs Market, By Vasodilators, 2019-2028 (In $ Million)
Figure 11: Europe Antihypertensive Drugs Market, By Other Drug Class, 2019-2028 (In $ Million)
Figure 12: Europe Antihypertensive Drugs Market, By End-User, In 2019
Figure 13: Europe Antihypertensive Drugs Market, By Hospital Pharmacy, 2019-2028 (In $ Million)
Figure 14: Europe Antihypertensive Drugs Market, By Retail Pharmacy, 2019-2028 (In $ Million)
Figure 15: Europe Antihypertensive Drugs Market, By E-Commerce Websites & Online Drug Stores, 2019-2028 (In $ Million)
Figure 16: Europe Antihypertensive Drugs Market, Country Outlook, 2019 & 2028 (In %)
Figure 17: The United Kingdom Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 18: France Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 19: Germany Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 20: Italy Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 21: Russia Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 22: Belgium Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 23: Poland Antihypertensive Drugs Market, 2019-2028 (In $ Million)
Figure 24: Rest Of Europe Antihypertensive Drugs Market, 2019-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - ANTIHYPERTENSIVE DRUGS
TABLE 2: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019, (IN $ MILLION)
TABLE 3: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028, (IN $ MILLION)
TABLE 4: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019, (IN $ MILLION)
TABLE 5: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, FORECAST YEARS, 2019-2028, (IN $ MILLION)
TABLE 6: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, HISTORIC YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)